Palestinian govt cancels deal with Israel for supply of 1 mn Covid vax

Pfizer vaccine

The Palestinian government on Friday announced cancellation of a deal with Israel relating to the supply of around one million doses of Pfizer (COVID-19) vaccine.

The cancellation came after the government found the doses fall short of meeting the technical criteria.

''After the technical teams of the Ministry of Health examined the first batch of the Pfizer vaccines that were received this evening from Israel, estimated at 90,000 doses, it was found that they do not conform to the specifications contained in the agreement, and accordingly, Prime Minister Mohammad Shtayyeh instructed the Minister of Health to cancel the agreement,'' WAFA news reported quoting government spokesman Ibrahim Melhem.

During a joint press conference with Health Minister Mai Alkaila, the official added that the first batch of the cancelled deal were returned to Israel.

Earlier on the day, Health Minister Mai Alkaila said that Palestine had received an offer from Pfizer to urgently obtain about one million Pfizer COVID-19 doses from Israel, provided that the manufacturer, at the end of this year, will hand over the same amount to the Israeli side that was initially supposed to be allocated to Palestine prior to the aforementioned Pfizer offer.

The ceasefire deal, between Israel and Palestine that was reached on May 21, was violated on June 16. Israel and Hamas concluded 11 days of fighting during which hundreds of rockets were launched from both Israel and Palestine sides. According to the Hamas-run Gaza Health Ministry, 253 Palestinians were killed during the fighting, including 66 children, while 13 Israelis, including a 5-year-old boy and a soldier, were killed.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel